Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
03/12/2009 | WO2008142102A3 Use of transferrin for preparing pharmaceutical compositions useful for treating bacterial infections as coadjuvants in antibiotic therapy |
03/12/2009 | WO2008141824A3 Preparative purification process for human furin |
03/12/2009 | WO2008140703A3 Synthetic peptide materials for joint reconstruction, repair and cushioning |
03/12/2009 | WO2008133511A3 Modified phosphatases |
03/12/2009 | WO2008132229A3 Highly concentrated insulin solutions and compositions |
03/12/2009 | WO2008117179A3 Polynucleotides and polypeptides of human factor vii gene, snps |
03/12/2009 | WO2008107122A3 Composition for the treatment of bone and/or cartilage defects |
03/12/2009 | WO2008062436A3 Antimicrobial derivatives of anacardic acid and process for preparing the same |
03/12/2009 | WO2008015675A3 Polypeptides and polynucleotides encoding same and use thereof in the treatment of medical conditions associated with ischemia |
03/12/2009 | WO2006073971A3 Binding protein with a scaffold for varying specificity |
03/12/2009 | US20090070890 Product |
03/12/2009 | US20090069623 Methods and compositions for treatment or prevention of radiation-induced fibrosis |
03/12/2009 | US20090069553 Gamma-1 and gamma-3 anti-human cd23 monoclonal antibodies and use thereof as therapeutics |
03/12/2009 | US20090069543 Factor IXa for the treatment of bleeding disorders |
03/12/2009 | US20090069537 compositions and methods to suppress the activation and/or proliferation of mesenchymally derived cells, as well as cells with abnormal growth characteristics; inhibit or eliminate fibrosis; cancer |
03/12/2009 | US20090069535 Ligand (ACT-4-L) to a Receptor on the Surface of Activated CD4+ T-Cells |
03/12/2009 | US20090069534 Hydrochloride salts of a glycopeptide phosphonate derivative |
03/12/2009 | US20090069428 Catalytic antioxidants and methods of use |
03/12/2009 | US20090069348 Use of Inhibitors of the Renin-Angiotensin System |
03/12/2009 | US20090069274 Interferon-like protein zcyto21 |
03/12/2009 | US20090069259 Treatment of neuropathic pain with zinc finger proteins |
03/12/2009 | US20090069258 Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereof |
03/12/2009 | US20090069251 Use Of Urokinase Inhibitors for the Treatment and/or Prevention of Neuropathological Diseases |
03/12/2009 | US20090069250 Inhibitors of Histone Deacetylase |
03/12/2009 | US20090069249 Methods for reducing oxidative stress in a cell with a sulfhydryl protected clutathione prodrug |
03/12/2009 | US20090069248 Substrate peptide sequences for plague plasminogen activator and uses thereof |
03/12/2009 | US20090069247 Use of tight junction antagonists to treat inflammatory bowel disease |
03/12/2009 | US20090069246 Methods for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
03/12/2009 | US20090069245 Ghrelin/growth hormone releasing peptide/growth hormone secretatogue receptor antagonists and uses thereof |
03/12/2009 | US20090069244 Mutants of lactoferrin |
03/12/2009 | US20090069243 Natriuretic activities |
03/12/2009 | US20090069242 Therapeutically active alpha msh analogues |
03/12/2009 | US20090069241 Compositions and Methods for Use of Pigment Epithelial Derived Factor (PEDF) Peptide Fragments |
03/12/2009 | US20090069240 Method of preventing and treating endocrine system disturbances |
03/12/2009 | US20090069238 Activatable clostridial toxins |
03/12/2009 | US20090069237 Methods and compositions for treating conditions |
03/12/2009 | US20090069236 PROCESS FOR THE PREPARATION OF HYPOALLERGENIC MAJOR BIRCH POLLEN ALLERGEN rBet v 1 |
03/12/2009 | US20090069235 IGF-1 Fusion Polypeptides and Therapeutic Uses Thereof |
03/12/2009 | US20090069234 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
03/12/2009 | US20090069233 Agonist Peptides of Basic Fibroblast Growth Factor (bFGF) and the Method of Reduction of Wrinkles on Skin, Darkening of Hair and Acceleration of Wound Healing |
03/12/2009 | US20090069232 Glycosylation of molecules |
03/12/2009 | US20090069231 Compositions and methods for treating diabetic eye disease |
03/12/2009 | US20090069230 Gdnf-derived peptides |
03/12/2009 | US20090069229 Plant-made west nile virus (wnv) vaccines, vectors and plant codon optimized sequences |
03/12/2009 | US20090069228 Screening Method |
03/12/2009 | US20090069227 Use of HMGB1 to promote stem cell migration and/or proliferation |
03/12/2009 | US20090069226 Transmucosal delivery of peptides and proteins |
03/12/2009 | US20090069225 Somatostatin analogues |
03/12/2009 | US20090069224 Linear and Cyclic Melanocortin Receptor-Specific Peptidomimetics |
03/12/2009 | US20090069223 Method for treatment of vascular hyperpermeability |
03/12/2009 | US20090069222 Compounds Useful as Modulators of the Proteasome Activity |
03/12/2009 | US20090069221 Somatostatin Analogue Formulations |
03/12/2009 | US20090069220 Dna-binding polyamide drug conjugates |
03/12/2009 | US20090069219 Deuterium-enriched telavancin |
03/12/2009 | US20090069218 Pharmaceutical compositions comprising casein derived peptides and methods of use thereof |
03/12/2009 | US20090069217 Nutrient composition |
03/12/2009 | US20090069216 Single-Chain Insulin Analogues and Pharmaceutical Formulations Thereof |
03/12/2009 | US20090069215 Acylated Single Chain Insulin |
03/12/2009 | US20090069214 Modulator of Metabolism Processes and Method of Its Receiving |
03/12/2009 | US20090069213 Compositions for Improving the Health and Appearance of Skin |
03/12/2009 | US20090068745 Compositions and methods for performing reverse gene therapy |
03/12/2009 | US20090068737 Methods of inhibiting interleukin-17 receptor |
03/12/2009 | US20090068722 produced by Paenibacillus polymyxa strain; for use in therapeutic feeds, reducing levels of colonization by target bacteria in poultry |
03/12/2009 | US20090068720 Useful polypeptides |
03/12/2009 | US20090068717 In vivo incorporation of unnatural amino acids |
03/12/2009 | US20090068698 Pregnancy-related enzyme activity |
03/12/2009 | US20090068636 Viral protein |
03/12/2009 | US20090068289 Formulation for menopausal women |
03/12/2009 | US20090068280 Controlled Release Interferon Drug Products and Treatment of HCV Infections Using Same |
03/12/2009 | US20090068278 Use of free radical scavengers for protecting and treating skin and hair damages caused by chemotherapy |
03/12/2009 | US20090068274 Highly efficient delivery of a large therapeutic mass aerosol |
03/12/2009 | US20090068270 Treatment of degenerated disc with autologous cells |
03/12/2009 | US20090068258 Caveolin-mimetic peptide for prevention and treatment of pulmonary hypertension and right ventricular hypertrophy |
03/12/2009 | US20090068251 Methods and compositions for promoting wound healing |
03/12/2009 | US20090068250 Bioresorbable and biocompatible compounds for surgical use |
03/12/2009 | US20090068246 Collagen-related peptides and uses thereof |
03/12/2009 | US20090068243 Novel formulations for delivery of antiviral peptide therapeutics |
03/12/2009 | US20090068236 Oral Cephalotaxine Dosage Forms |
03/12/2009 | US20090068229 Modified surface antigen |
03/12/2009 | US20090068227 Use of neurotoxin therapy for treatment of urologic and related disorders |
03/12/2009 | US20090068224 Method to identify polypeptide toll-like receptor (tlr) ligands |
03/12/2009 | US20090068216 Modified surface antigen |
03/12/2009 | US20090068207 Compositions Containing Beta 2-Glycoprotein I-Derived Peptides for the Prevention and/or Treatment of Vascular Disease |
03/12/2009 | US20090068205 Antiproliferative agents; anticancer agents; composition comprising antagonist of a human ErbB4 receptor, in admixture with a pharmaceutically acceptable carrier; antagonist selected from group consisting of an antibody produced by a hybridoma selected from the group containing HER4.10H1.1A1 |
03/12/2009 | US20090068203 Methods for treating cardiovascular disease using a soluble CTLA4 Molecule |
03/12/2009 | US20090068201 Methods of treatment using antibodies to neutrokine-alpha |
03/12/2009 | US20090068199 Methods for Treating and Detecting Beta-Cell Disease |
03/12/2009 | US20090068193 Treatment And Prophylaxis With 4-1BB-Binding Agents |
03/12/2009 | US20090068188 C-C chemokine receptor 3 proteins |
03/12/2009 | US20090068187 Novel 14275, 54420, 8797, 27439, 68730, 69112 and 52908 molecules and uses therefor |
03/12/2009 | US20090068185 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
03/12/2009 | US20090068178 Compositions and Methods for the Treatment of Tumor of Hematopoietic Origin |
03/12/2009 | US20090068174 Therapeutic alkaline protease compositions and use in facilitating the transport of agents across the gastrointestinal mucosal lining |
03/12/2009 | US20090068169 2,4,6-triamino-s-triazine-based compounds which bind to the tail (fc) portion of immunoglobulins and their use |
03/12/2009 | US20090068168 Substituted amino alcohols |
03/12/2009 | US20090068167 Compositions for promoting wound healing and treating psoriasis |
03/12/2009 | US20090068166 Method and composition for protection against radiation |
03/12/2009 | US20090068165 Uniformly Conjugated Serine Hydrolases |
03/12/2009 | US20090068164 Sequence enabled reassembly (seer) - a novel method for visualizing specific dna sequences |
03/12/2009 | US20090068162 Stationary Phase Antibody Arrays for Trace Protein Analysis |